Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects

Clinical trial NCT05385770 · COMPLETED

Trial details

NCT number: NCT05385770
Sponsor: Celltrion
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Essential Hypertension

Start date: 2022-07-08
Primary completion: 2024-07-11
Enrollment: 890

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.